Switch to:
More From Other Websites
Kyowa Hakko Kirin and Bristol-Myers Squibb Announce Immuno-Oncology Clinical Collaboration Studying... Jul 29 2015
Kyowa Hakko Kirin and Bristol-Myers Squibb Announce Immuno-Oncology Clinical Collaboration Studying... Jul 29 2015
Kyowa Hakko Kirin and Bristol-Myers Squibb Announce Immuno-Oncology Clinical Collaboration Studying... Jul 29 2015
BRISTOL MYERS SQUIBB CO Financials Jul 29 2015
Bristol-Myers Squibb Co. Earnings Analysis: By the Numbers Jul 29 2015
Abbott Laboratories Earnings Analysis: By the Numbers Jul 29 2015
Gilead beats Street 2Q forecasts on surge in sales, profit Jul 28 2015
Gilead beats Street 2Q forecasts on surge in sales, profit Jul 28 2015
Drugmaker Pfizer tops Street 2Q forecasts, raises forecast Jul 28 2015
Drugmaker Pfizer tops Street 2Q forecasts, raises forecast Jul 28 2015
European Medicines Agency Validates Two Parallel Type II Variation Applications to Extend the Opdivo... Jul 28 2015
Short Sellers Run For Cover From Major Pharma Jul 27 2015
European Medicines Agency Validates and Grants Accelerated Assessment of Marketing Authorization... Jul 27 2015
European Medicines Agency Validates and Grants Accelerated Assessment of Marketing Authorization... Jul 27 2015
10-Q for Bristol-Myers Squibb Co. Jul 25 2015
Bristol-Myers wins approval for 1st hepatitis C type 3 drug Jul 24 2015
Bristol-Myers wins approval for 1st hepatitis C type 3 drug Jul 24 2015
UPDATE 2-AbbVie, Bristol-Myers get FDA nod for hep C treatments Jul 24 2015
FDA Approves Daklinza (daclatasvir) for the Treatment of Patients with Chronic Hepatitis C Genotype... Jul 24 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK